OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 182

Showing 26-50 of 182 citing articles:

Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Abigail E. Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 1-14
Open Access | Times Cited: 19

The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis
Arman Shafiee, Razman Arabzadeh Bahri, M. Rafiei, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 425-431
Closed Access | Times Cited: 7

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health
Sam Gandy, Matthias Forstmann, Robin Carhart‐Harris, et al.
Health Psychology Open (2020) Vol. 7, Iss. 2
Open Access | Times Cited: 47

Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin
Tracey Varker, Loretta Watson, Kari Gibson, et al.
Journal of Psychoactive Drugs (2020) Vol. 53, Iss. 1, pp. 85-95
Closed Access | Times Cited: 41

LSD use in the United States: Trends, correlates, and a typology of us
Brittany Killion, Audrey Hang Hai, Abdulaziz Alsolami, et al.
Drug and Alcohol Dependence (2021) Vol. 223, pp. 108715-108715
Closed Access | Times Cited: 40

Review of otential sychedelic reatments for PTSD
Ryan L. Henner, Matcheri S. Keshavan, Kevin P. Hill
Journal of the Neurological Sciences (2022) Vol. 439, pp. 120302-120302
Closed Access | Times Cited: 25

Pharmahuasca and DMT Rescue ROS Production and Differentially Expressed Genes Observed after Predator and Psychosocial Stress: Relevance to Human PTSD
D. Parker Kelley, Katy Venable, Aspasia Destouni, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 2, pp. 257-274
Open Access | Times Cited: 23

Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia
Nicolas G. Glynos, Jennifer Pierce, Alan K. Davis, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 1, pp. 73-84
Closed Access | Times Cited: 23

Psilocybin for Trauma-Related Disorders
Amanda Khan, Ellen Bradley, Aoife O’Donovan, et al.
Current topics in behavioral neurosciences (2022), pp. 319-332
Closed Access | Times Cited: 23

Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights
Salma Laabi, Claire LeMmon, Callie Vogel, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111753-111753
Closed Access | Times Cited: 5

Treatment Approaches for Posttraumatic Stress Disorder Derived from Basic Research on Fear Extinction
Jessica L. Maples‐Keller, Laura E. Watkins, Natalie Hellman, et al.
Biological Psychiatry (2024)
Closed Access | Times Cited: 4

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Daniel A Kinderlehrer
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 141-155
Open Access

Understanding Suicidal Thoughts and Behaviors Among LGBTQ + Youth: Differential Associations Between Bullying and Substance Use
Cayson W. Tiedge, Alberto Valido, Matthew Rivas‐Koehl, et al.
Prevention Science (2025)
Closed Access

Cultural Humility and Psychedelics: A Framework Analysis of Psychedelic-Assisted Therapy Manuals and Practice Guidelines
A. Bell, Bianca R. Watt, Arturo S. Lopez Flores, et al.
Research Square (Research Square) (2025)
Closed Access

The effect of low-dose psilocybin on brain neurotransmission and rat behavior
Agnieszka Bysiek, Adam Wojtas, Izabela Szpręgiel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111347-111347
Closed Access

Prescribing in Children and Adolescents

(2025), pp. 561-626
Closed Access

Relational Processes in Ayahuasca Groups of Palestinians and Israelis
Leor Roseman, Yiftach Ron, Antwan Saca, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28

Psychedelic Psychotherapy: Building Wholeness Through Connection
Gita Vaid, Barry C. Walker
Global Advances in Health and Medicine (2022) Vol. 11, pp. 2164957X2210811-2164957X2210811
Open Access | Times Cited: 16

Psychoactive substances for the treatment of neuropsychiatric disorders
Zifan Zhen, Xueqiang Sun, Shiying Yuan, et al.
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104193-104193
Closed Access | Times Cited: 3

Exploring the Regulatory Framework of Psychedelics in the US & Europe
Hitesh Kumar Behera, Ramesh Joga, Sravani Yerram, et al.
Asian Journal of Psychiatry (2024) Vol. 102, pp. 104242-104242
Closed Access | Times Cited: 3

Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI
Praachi Tiwari, Pasha A. Davoudian, Darshana Kapri, et al.
Neuron (2024) Vol. 112, Iss. 22, pp. 3697-3714.e6
Closed Access | Times Cited: 3

Serotonergic Psychedelics in Neural Plasticity
Kacper Łukasiewicz, Jacob J. Baker, Yi Zuo, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 21

Scroll to top